These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy. Kralikova E; Kmetova A; Stepankova L; Zvolska K; Davis R; West R Addiction; 2013 Aug; 108(8):1497-502. PubMed ID: 23668486 [TBL] [Abstract][Full Text] [Related]
23. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist. Tonstad S J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731 [TBL] [Abstract][Full Text] [Related]
24. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates. Hajek P; McRobbie HJ; Myers KE; Stapleton J; Dhanji AR Arch Intern Med; 2011 Apr; 171(8):770-7. PubMed ID: 21518946 [TBL] [Abstract][Full Text] [Related]
25. The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial. Hoogsteder PH; Kotz D; van Spiegel PI; Viechtbauer W; Brauer R; Kessler PD; Kalnik MW; Fahim RE; van Schayck OC BMC Public Health; 2012 Dec; 12():1052. PubMed ID: 23216646 [TBL] [Abstract][Full Text] [Related]
26. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR; JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546 [TBL] [Abstract][Full Text] [Related]
27. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial. Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210 [TBL] [Abstract][Full Text] [Related]
29. Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo. Gonzales D; Jorenby DE; Brandon TH; Arteaga C; Lee TC Addiction; 2010 Nov; 105(11):2002-13. PubMed ID: 20819082 [TBL] [Abstract][Full Text] [Related]
30. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial. Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840 [TBL] [Abstract][Full Text] [Related]
31. An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers. McClure EA; Baker NL; Gipson CD; Carpenter MJ; Roper AP; Froeliger BE; Kalivas PW; Gray KM Am J Drug Alcohol Abuse; 2015 Jan; 41(1):52-6. PubMed ID: 25062287 [TBL] [Abstract][Full Text] [Related]
32. Health and economic effects from linking bedside and outpatient tobacco cessation services for hospitalized smokers in two large hospitals: study protocol for a randomized controlled trial. Fellows JL; Mularski R; Waiwaiole L; Funkhouser K; Mitchell J; Arnold K; Luke S Trials; 2012 Aug; 13():129. PubMed ID: 22853325 [TBL] [Abstract][Full Text] [Related]
33. Sibutramine for weight gain attenuation during smoking cessation with varenicline: a pilot study. Sood A; Ebbert JO; Clark MM; Croghan IT; Schroeder DR; Hays JT Nicotine Tob Res; 2009 Dec; 11(12):1479-84. PubMed ID: 19884116 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of varenicline to prompt quit attempts in smokers not currently trying to quit: a randomized placebo-controlled trial. Hughes JR; Rennard SI; Fingar JR; Talbot SK; Callas PW; Fagerstrom KO Nicotine Tob Res; 2011 Oct; 13(10):955-64. PubMed ID: 21652735 [TBL] [Abstract][Full Text] [Related]
35. Increasing the dose of varenicline in patients who do not respond to the standard dose. Jiménez-Ruiz CA; Barrios M; Peña S; Cicero A; Mayayo M; Cristóbal M; Perera L Mayo Clin Proc; 2013 Dec; 88(12):1443-5. PubMed ID: 24290118 [TBL] [Abstract][Full Text] [Related]
36. Interactive voice response telephony to promote smoking cessation in patients with heart disease: a pilot study. Reid RD; Pipe AL; Quinlan B; Oda J Patient Educ Couns; 2007 Jun; 66(3):319-26. PubMed ID: 17336026 [TBL] [Abstract][Full Text] [Related]
37. Observational study of safety and efficacy of varenicline for smoking cessation among Filipino smokers. Park PW; Casiano EM; Escoto L; Claveria AM Curr Med Res Opin; 2011 Oct; 27(10):1869-75. PubMed ID: 21838412 [TBL] [Abstract][Full Text] [Related]
38. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. Tonstad S; Tønnesen P; Hajek P; Williams KE; Billing CB; Reeves KR; JAMA; 2006 Jul; 296(1):64-71. PubMed ID: 16820548 [TBL] [Abstract][Full Text] [Related]
39. Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment. Hajek P; Tønnesen P; Arteaga C; Russ C; Tonstad S Addiction; 2009 Sep; 104(9):1597-602. PubMed ID: 19686530 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Rigotti NA; Pipe AL; Benowitz NL; Arteaga C; Garza D; Tonstad S Circulation; 2010 Jan; 121(2):221-9. PubMed ID: 20048210 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]